Prof. Geert Baggerman (Sr. Researcher VITO Health and Head of the Center for Proteomics of University Antwerp) and his expert team have built an important expertise in mass spectrometry-based peptide analysis. They have been using their unique peptidomics expertise to setup a ‘state of the art’ MS-based immuno-peptidomics platform to serve the biotech and biopharma industry in supporting their immunotherapy development.
I was asked to screen the interest for a MS-based immuno-peptidomics service platform in the immunotherapy and adoptive cell therapy market by interviewing relevant SME and large biotechs in Europe. I made an estimation of the business potential and setup pricing & potential business models. I also mapped the competitive landscape of service providers and the IP landscape, and I calculated the financial needs to raise a professional service platform.
Recently the spin-off ImmuneSpec has been setup.